|
| View:
Latest News | Top Stories |
|
| 1.
|
SCOLR Pharma, Inc. Licenses Dietary Supplements
-
PR Newswire
-
2 hours, 51 minutes ago
SCOLR Pharma, Inc. announced that on November 20, 2009 it licensed to Chrono Nutraceuticals LLC exclusive rights in Canada to manufacture and sell four extended release dietary supplements using SCOLR's proprietary CDT® drug delivery platform.
|
|
| 2.
|
Chembio Diagnostics Donates 4,500 HIV Test Kits for World AIDS Day
-
Marketwire
-
Tue 8:30 am ET
|
|
| 3.
|
Icagen to Present at the 63rd Annual Meeting of the American Epilepsy Society
-
GlobeNewswire
-
Tue 8:30 am ET
RESEARCH TRIANGLE PARK, N.C. -- Icagen, Inc. today announced that data related to the Company's Phase I program for ICA-105665, the Company's lead drug candidate for the treatment of epilepsy and pain, will be presented as poster presentations at the 63rd Annual Meeting of the American Epilepsy Society on Saturday, December 5, 2009 in Boston, Massachusetts.
|
|
| 4.
|
Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
-
PR Newswire
-
Tue 7:30 am ET
Palatin Technologies, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,622,440, titled "Cyclic Natriuretic Peptide Constructs."
|
|
| 5.
|
Immunomedics to Present at 51st ASH Annual Meeting
-
GlobeNewswire
-
Mon 8:30 am ET
MORRIS PLAINS, N.J. -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that nine presentations involving its product candidates will be given at the 51st American Society of Hematology Annual Meeting, scheduled for December 5 - 8, 2009, in New Orleans, LA.
|
|
| 6.
|
Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference
-
PR Newswire
-
Wed Nov 25
Abaxis, Inc. , a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the 21st Annual Piper Jaffray Health Care Conference on Wednesday, December 2, 2009 at 2:00 p.m.
|
|
| 7.
|
Raptor's genetic disorder drug meets study goals
-
AP
-
Mon Nov 23
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
|
|
| 8.
|
Nymox Releases Positive New Clinical Trial Data on Durability of Benefits for Early Responders to Company's BPH Drug NX-1207
-
GlobeNewswire
-
Mon Nov 23
HASBROUCK HEIGHTS, N.J. -- Nymox Pharmaceutical Corporation announced today the release of positive new clinical trial data from responder analysis of the Company's pooled multi-center U.S.
|
|
| 9.
|
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
-
PR Newswire
-
Mon Nov 23
Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco.
|
|
| 10.
|
Neogen's board approves 3-for-2 stock split
-
AP
-
Mon Nov 16
Neogen Corp., which makes test kits for food and animal safety, said Monday its board approved a 3-for-2 stock split. Shareholders of record on Nov. 30 will receive one additional share of stock for each two shares held.
|
|
